TrialJAMA cardiology2025

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial.

Siddharth M Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.